The linkurl:National Institutes of Health; (NIH) and the linkurl:US Food and Drug Administration; (FDA) linkurl:announced a new collaboration; this morning (Feb 24) that will support efforts in translational and regulatory science, including a contribution of $6.75 million in regulatory research grants over the next three years.
Image: Wikimedia commons
Since Margaret Hamburg took the reins as FDA commissioner last year, she has not been shy about her feelings regarding regulatory science -- research that relates the regulatory requirements of biomedical product development to the science that ensures the safety and efficacy of those products. If the production of new therapeutics were a rower, linkurl:Hamburg has said,; it would have one strong arm -- that of fundamental biomedical research and discovery -- but one scrawny arm -- the regulatory science counterpart. And unless the scrawny arm begins to bulk up, the translational side of research will largely just be moving in...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?